QyQ, I actually did a high-level estimate a while back of several options i.e. 1) contract manufacturing; 2) opening a new manufacturing facility; or 3) or merging with a manufacturer and the most cost effective solution is actually to merge with someone like an ANI. This is the right strategy for Biosante, again, the problem is the valuation for BPAX is way out of whack and us shareholders need to hold strong and force these guys back to re-structure this new deal. A 43% ownership is UNACCEPTABLE, period. We need no less than 49.9%. Furthermore, Biosante management needs to get rid of the CVRs OR they themselves should accept the same CVRs in place of their golden parachute. If they do these two things I will vote YES.
CAUTION: Do NOT rely on information from ShortAnalytics - it is unreliable because the total volume is inaccurate!